Adi Mohanty
2022
In 2022, Adi Mohanty earned a total compensation of $3.5M as Chief Executive Officer at BIORA THERAPEUTICS, a 65% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $288,750 |
|---|---|
| Option Awards | $1,492,015 |
| Salary | $550,000 |
| Stock Awards | $1,171,875 |
| Other | $20,070 |
| Total | $3,522,710 |
Mohanty received $1.5M in option awards, accounting for 42% of the total pay in 2022.
Mohanty also received $288.8K in non-equity incentive plan, $550K in salary, $1.2M in stock awards and $20.1K in other compensation.
Rankings
In 2022, Adi Mohanty's compensation ranked 1,018th out of 5,760 executives tracked by ExecPay. In other words, Mohanty earned more than 82.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,018 out of 5,760 | 82nd |
Division Manufacturing | 478 out of 3,136 | 85th |
Major group Chemicals And Allied Products | 172 out of 1,422 | 88th |
Industry group Drugs | 155 out of 1,323 | 88th |
Industry Pharmaceutical Preparations | 114 out of 969 | 88th |
Source: SEC filing on April 27, 2023.
Mohanty's colleagues
We found two more compensation records of executives who worked with Adi Mohanty at BIORA THERAPEUTICS in 2022.